Nootropil (Piracetam) 800 mg 60 tablets
Nootropil (Piracetam) improves brain function and stimulates the central nervous system without any toxicity or addictive properties. Piracetam is a member of the class of drugs known as nootropics or 'smart drugs'. Nootropics are known commonly as cognitive enhancers, improving cognitive functions of the brain such as memory, attention and intelligence.
Piracetam also has a beneficial effect upon the brain's Corpus Callosum. This is the area of the brain that joins the two hemispheres, linking the logical side of the brain with the creative side of the brain, allowing the user to draw on greater brain potential.
Piracetam has been used successfully to treat alcoholism and alcohol withdrawal syndrome in animals and man. It has brought improvement, or slowed deterioration, in ‘senile involution’ dementia and Alzheimer’s disease. Piracetam has improved recovery from aphasia (speech impairment) after stroke, and restored various functions (use of limbs, speech, EEG, state of consciousness) in people suffering from acute and chronic cerebral ischaemia (decreased brain blood flow). Piracetam has improved alertness, co-operation, socialisation and IQ in elderly psychiatric patients suffering from ‘mild diffuse cerebral impairment.’
Piracetam has increased reading comprehension and accuracy in dyslexic children. It increased memory and verbal learning in dyslexic children, as well as speed and accuracy of reading, writing and spelling. Piracetam potentiated the anticonvulsant action of various anti-epileptic drugs in both animals and man, while also eliminating cognitive deficits induced by anti-epileptic drugs in humans. It has improved mental performance in ‘aging, non-deteriorated individuals’ suffering only from ‘middle-aged forgetfulness’. Elderly out-patients suffering from ‘age-associated memory impairment’ given Piracetam showed significant improvement in memory consolidation and recall. Piracetam reversed typical EEG slowing associated with ‘normal’ and pathological human aging, increasing alpha and beta (fast) EEG activity and reducing delta and theta (slow) EEG activity, while simultaneously increasing vigilance, attention and memory.
The effect of Piracetam can be increased if taken with DMAE, Centrophenoxine, Choline or Hydergine. When Choline and Piracetam are taken together there is a synergistic effect that causes a greater improvement in memory than the sum of each when taken alone.
A common starting dose is three 800 mg tablets twice a day, lowering to one or two tablets twice a day after a month. States of mental deterioration: Administer a daily dosage of 4.8 g of Piracetam (6 tablets per day) for the first few weeks. Then lower the daily dosage to 2.4 g (3 tablets per day). Cortical Myoclonias: Because the therapeutic response is quite variable, the dosage should be adjusted to the patient’s own needs. A recommended protocol would be to begin treatment with 7.2 g of Piracetam daily, increasing this dosage by 4.8 g per day, every 3 or 4 four days until obtaining a satisfactory response or a maximum dose of 24 g daily. Subsequently and depending on the results obtained, the dosage of other anti-myoclonic treatments should be reduced if possible. When adjusting the posology, follow your doctor’s instructions. Once treatment with Piracetam has begun, it should be continued for as long as the cerebral pathology persists. Nonetheless, every 6 months an effort should be made to reduce or stop treatment. To prevent the sudden reappearance of the disorder, withdrawal should be carried out by reducing the dosage by ½ g every 2 days.
Since Piracetam is eliminated in urine, patients with renal insufficiency should take this drug with caution. Abrupt suspension of treatment should be avoided, since this can cause a myoclonic or general crisis in certain myoclonic patients.
Cases have been reported of nervousness, irritability, insomnia, anxiety, trembling and agitation and, in certain patients, fatigue and drowsiness. Occasional dryness of the mouth, increased libido, weight gain and hypersensitive skin reactions. These side effects are generally shown in elderly patients. In the majority of cases, such symptoms subside with a reduced dosage. If any other adverse reaction not described in this leaflet should occur, consult your doctor or chemist.
A single case has been reported in which the concomitant use of Piracetam and thyroid hormone extracts (T3 + T4) has produced confusion, irritability and sleeping disorders. Its interaction with other drugs has not been described.
Remember that all nootropics are synergistic with each other and with other brain nutrition products (such as, Choline, DMAE, Hydergine and Centrophenoxine). When combining these products, the individual doses may have to be reduced in order to avoid possible side effects of nausea and headaches. The safety of using this product during pregnancy has not been sufficiently established. Although studies in animals have not shown teratogenic effects or effects on fertility, using this drug during pregnancy is not recommended except under a doctor’s strict supervision and only when the benefits justify possible risks. Likewise, breast-feeding is not recommended. This pharmaceutical product contains Orange Yellow S as an excipient. This may cause allergic reactions, including asthma, especially in patients allergic to acetylsalicylic acid.
Keep Nootropil out of children’s reach and sight. No special storage conditions are required. Do not use this pharmaceutical drug after the expiry date shown on the box.
These statements have not been evaluated by the FDA or Health Canada. This product is not intended to diagnose, cure or prevent disease.